1. Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells.
   Yuliang Wang et al, 2015, Mol Med Rep CrossRef
2. Role of the extracellular matrix in cancer-associated epithelial to mesenchymal transition phenomenon
   George Tzanakakis et al, 2017, Dev. Dyn. CrossRef
3. Imaging the expression of glypican-3 in hepatocellular carcinoma by PET
   Zhen Wang et al, 2017, Amino Acids CrossRef
4. Role of glycanation and convertase maturation of the soluble Glypican-3 in inhibiting proliferation of hepatocellular carcinoma cells
   Ahmad Saad et al, 2018, Biochemistry CrossRef
5. Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
   Fubo Zhou et al, 2018, Med Res Rev CrossRef
6. Polyclonal antibody production against rGPC3 and their application in diagnosis of hepatocellular carcinoma
   Shenghao Wang et al, 2018, Preparative Biochemistry and Biotechnology CrossRef
7. Both glypican-3/Wnt/β-catenin signaling pathway and autophagy contributed to the inhibitory effect of curcumin on hepatocellular carcinoma
   Pei Hu et al, 2018, Digestive and Liver Disease CrossRef
8. Phosphorothioate-Modified AP613-1 Specifically Targets GPC3 when Used for Hepatocellular Carcinoma Cell Imaging
   Lili Dong et al, 2018, Molecular Therapy - Nucleic Acids CrossRef
9. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma
   Youcai Li et al, 2019, Mol Imaging Biol CrossRef
10. null
    Arthur Zimmermann, 2016 CrossRef
11. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells
    Ying Liu et al, 2015, Tumor Biol. CrossRef
12. PiggyBac-engineered T cells expressing a glypican-3-specific chimeric antigen receptor show potent activities against hepatocellular carcinoma.
    Pei Wang et al, 2020, Immunobiology CrossRef
13. KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma
    Lei Shi et al, 2016, BMC Cancer CrossRef
14. null
    Arthur Zimmermann, 2017 CrossRef
15. Glypican-1 in human glioblastoma: implications in tumorigenesis and chemotherapy
    Eduardo Listik et al, 2020, Oncotarget CrossRef
16. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells
    Lilian Fedra Castillo et al, 2016, Oncotarget CrossRef
17. Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinoma
    Tsung-Chieh Shih et al, 2020, Liver Research CrossRef
18. Prognostic Nomogram for Sorafenib Benefit in Hepatitis B Virus-Related Hepatocellular Carcinoma After Partial Hepatectomy
    Wei Dong et al, 2021, Front. Oncol. CrossRef
19. SPECT Imaging of Hepatocellular Carcinoma Detection by the GPC3 Receptor
    Haoran Xu et al, 2021, Mol. Pharmaceutics CrossRef
20. Magnetic resonance imaging and diffusion-weighted imaging-based histogram analyses in predicting glypican 3-positive hepatocellular carcinoma
    Jiangtao Zhao et al, 2021, European Journal of Radiology CrossRef
21. Therapeutic effect of curcumin in gastrointestinal cancers: A comprehensive review
    Korosh Morshedi et al, 2021, Phytotherapy Research CrossRef
22. Current Trends in Non-Invasive Imaging of Interactions in the Liver Tumor Microenvironment Mediated by Tumor Metabolism
    Isabel Theresa Schobert et al, 2021, Cancers CrossRef
23. Overexpression of Glypican 5 (GPC5) Inhibits Prostate Cancer Cell Proliferation and Invasion via Suppressing Sp1-Mediated EMT and Activation of Wnt/β-Catenin Signaling
    Yu Sun et al, 2018, oncol res CrossRef
24. Proteoglycans Determine the Dynamic Landscape of EMT and Cancer Cell Stemness
    Zoi Karagiorgou et al, 2022, Cancers CrossRef
25. Value of biomarkers in epithelial–mesenchymal transition models of liver cancer under different interventions: a meta-analysis
    Jing Yan et al, 2023, Future Oncology CrossRef
26. Fucoidan from Spatoglossum schröederi promotes B16-F10 malignancy features modulation and antimelanoma in vivo activities
    D.L. Bellan et al, 2023, Algal Research CrossRef
27. Predicting glypican-3 expression in hepatocellular carcinoma: A comprehensive analysis using combined contrast-enhanced ultrasound and clinical factors
    Nana Li et al, 2023, CH CrossRef
28. 20(S)-Ginsenoside Rh2 inhibits hepatocellular carcinoma by suppressing angiogenesis and the GPC3‐mediated Wnt/β‑catenin signaling pathway
    Linfei Xu et al, 2024, ABBS CrossRef
29. Synthesis and preclinical evaluation of a novel probe [18F]AlF-NOTA-IPB-GPC3P for PET imaging of GPC3 positive tumor
    Chunwei Mo et al, 2024, Bioorganic Chemistry CrossRef